Nektar Therapeutics NKTR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
16.58quote price arrow up+0.07 (+0.42%)
Volume
418,591
Close
16.51quote price arrow up+0.25 (+1.54%)
Volume
1,329,519
52 week range
12.92 - 26.75
Loading...
  • Open16.26
  • Day High16.58
  • Day Low15.94
  • Prev Close16.26
  • 52 Week High26.75
  • 52 Week High Date02/17/21
  • 52 Week Low12.92
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap3.035B
  • Shares Out183.80M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change-2.88

KEY STATS

  • Open16.26
  • Day High16.58
  • Day Low15.94
  • Prev Close16.26
  • 52 Week High26.75
  • 52 Week High Date02/17/21
  • 52 Week Low12.92
  • 52 Week Low Date08/20/21
  • Market Cap3.035B
  • Shares Out183.80M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change-2.88

RATIOS/PROFITABILITY

  • EPS (TTM)-2.62
  • P/E (TTM)-6.29
  • Fwd P/E (NTM)-5.72
  • EBITDA (MRQ)-419.788M
  • ROE (MRQ)-43.89%
  • Revenue (MRQ)105.47M
  • Gross Margin (MRQ)77.89%
  • Net Margin (MRQ)-449.67%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nektar Therapeutics

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nektar Therapeutics is a biopharmaceutical company. The Company discovers and develops medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes treatments for cancer and autoimmune disease. It has research and development (R&D) pipeline of medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. It leverages its chemistry platform to discover and design new drug...
Robert Chess
Non-Executive Chairman
Howard Robin
Chief Executive Officer
Gilbert Labrucherie J.D.
Chief Financial Officer
Address
455 Mission Bay Blvd S
San Francisco, CA
94158-2158
United States

Top Peers

SYMBOLLASTCHG%CHG
RLAY
Relay Therapeutics Inc
37.09+0.09+0.24%
BCRX
BioCryst Pharmaceuticals Inc
15.70+0.49+3.22%
AGIO
Agios Pharmaceuticals Inc
47.14+1.34+2.93%
NSTG
NanoString Technologies Inc
57.69+3.19+5.85%
KYMR
Kymera Therapeutics Inc
62.95-1.95-3.00%